Press Releases

  • April 05, 2024
  • RadSite Launches Monthly Complimentary Webinar Series
  • Presentations will cover a wide range of imaging and accreditation topics
  • RadSite™, a leading accrediting agency promoting performance and quality-based imaging practices, today announced the launch of a complimentary, monthly webinar series beginning in May 2024. The series will cover key trends in advanced diagnostic imaging, including CT, MRI, Nuclear Medicine, and Cone Beam CT, and other related topics. RadSite will use a roundtable discussion format for most webinars to keep the conversation engaging and to promote audience participation.

  • March 27, 2024
  • Physicians for MA Beneficiaries Express Concerns About How Medicare Reimbursement Cutbacks Will Harm Senior Citizens
  • Supplement letter urges immediate changes to V28 risk adjustment initiative
  • Physicians for MA Beneficiaries (the Coalition), a non-profit organization of physician groups providing value-based care to Medicare patients, has distributed a supplemental comment letter to the Centers for Medicare & Medicaid Services (CMS) addressing the adverse impact on Medicare Advantage (MA) beneficiaries of the new risk adjustment model being implemented in the MA program. The letter highlights significant concerns related to the quality of care and scope of services for the Coalition members’ Medicare patients in the future if the MA funding continues to fall under the new model that excludes risk adjustment for many common and costly chronic conditions.

  • July 13, 2023
  • Dr. Mark Hiatt Joins RadSite as Chief Medical Officer
  • Dr. Hiatt to help supervise accreditation programs, new standards, and auditing program
  • Annapolis, MD / July 13, 2023 – RadSite,™ a leading accrediting organization promoting quality-based imaging practices, announced today the appointment of Mark Hiatt, MD, MBA, MS, as its Chief Medical Officer. In his new role, Dr. Hiatt will help oversee RadSite’s quality-benchmarking programs, support several key committees, participate in RadSite’s audit program, and assist in the development of new accreditation standards.

  • June 28, 2023
  • Verbal Beginnings Receives Accreditation from Autism Commission on Quality (ACQ)
  • ABA Provider one of the first to be accredited pursuant to ACQ’s new Applied Behavior Analysis Accreditation Program Standards and Guide, version 1.0
  • LOUISVILLE, Kentucky, June 28, 2023 – The Autism Commission on Quality (ACQ) is pleased to announce the following locations operated by Verbal Beginnings, LLC have been awarded a full 2-year accreditation pursuant to ACQ’s new Applied Behavior Analysis Accreditation Program Standards and Guide, version 1.0:

  • June 28, 2023
  • Anchors Aweigh ABA Receives Accreditation from Autism Commission on Quality (ACQ)
  • ABA Provider one of the first to be accredited pursuant to ACQ’s new Applied Behavior Analysis Accreditation Program Standards and Guide, version 1.0
  • LOUISVILLE, Kentucky, June 28, 2023 – The Autism Commission on Quality (ACQ) is pleased to announce Anchors Aweigh ABA, LLC’s location in St. Johns County, Florida has been awarded a full 2-year accreditation pursuant to ACQ’s new Applied Behavior Analysis Accreditation Program Standards and Guide, version 1.0. The newly accredited program offers applied behavior analysis (ABA) healthcare services to individuals and families impacted by autism in St. Johns and Duval Counties in Florida.

  • May 10, 2023
  • Bryan Warf, PhD Joins The Center for Genomic Interpretation Team as Senior Director of Scientific Affairs
  • Wharf to Provide Clinical Expertise on ELEVATEGENETICS services and Large Research Projects
  • Bryan Warf, PhD has joined the Center for Genomic Interpretation (CGI) as the 501(c)(3) nonprofit’s Senior Director of Scientific Affairs. Dr. Warf brings almost two decades of clinical science experience and expertise to CGI. He will be supporting CGI’s TestWisely and ELEVATEGENETICS initiatives that focus on quality driving programs that encompass germline (inherited) genetics, genomics and precision medicine.

Scroll to Top